Skip to content

Cold hemodialysis effect on quality of life and anemia.

The impact of cold dialysis fluid based on quality of life and health of anemia in hemodialysis patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015062722930N1
Enrollment
60
Registered
2017-09-11
Start date
2015-06-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ESRD. Chronic kidney disease, stage 5

Interventions

Naturally hemodialysis fluids for dialysis patients is 37 ° C. The study used groups of 35 ° C. A cross-over study that temperature change (intervention) in the intervention group runs..
Naturally hemodialysis fluids for dialysis patients is 37 ° C. The study used groups of 35 ° C. A cross-over study that temperature change (intervention) in the intervention group runs.

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria for the study included(Type of vascular access is a fistula; Round pump, type and UF filtration and hemodialysis devices Standard hemodialysis and cooled in two stages before and after the intervention to be fixed; Patients on hemodialysis three times a week and each session will be 4 hours; At least 6 months prior to their undergoing hemodialysis). Exclusion criteria were(Patients with acute physical and psychological problems (such as divorce, death of a loved one, financial problems, create new chronic disease) only in one of the courses are standard hemodialysis or cold; Patients undergoing hemodialysis them for any reason (kidney transplantation, vascular access problem) is interrupted; Patients who are on dialysis due to acute kidney failure; dialysis patients regime change them for any reason; Patients who are treated for mental health problems; patients who are experiencing acute bleeding; blood transfusion patients who receive).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of life. Timepoint: Baseline,The first 4 weeks after sampling, The second four weeks after sampling. Method of measurement: SF36.;Anemia. Timepoint: Baseline, the end of each week In the first 4 weeks and In thesecond 4 weeks After sampling. Method of measurement: cell count.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Moradi

Zanjan University of Medical Sciences

moradifha@gmail.com - moradifha@zums.ac.ir00982433148353 - 00982433148367

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026